Direction Change Ahead, What to Expect - Research & Analysis on Achillion Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated

JAKARTA, INDONESIA -- (Marketwire) -- 11/13/12 -- Moments ago, TradersInsight.net introduced new coverage of Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX). Full outlook, analysis and consensus opinion is available to readers via the links below.

www.TradersInsight.net/r/cnbc/7f00_ACHN
www.TradersInsight.net/r/cnbc/0c25_VRTX

The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include grim European forecasts with Germany's growth prospects signaling potential trouble ahead, headlines of "fiscal cliff" concerns with potential friction between Republicans and Democrats regarding upcoming expiration of tax cuts and recent effects of Hurricane Sandy still affecting major areas. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.

Traders Insight is releasing new coverage on Achillion Pharmaceuticals, Inc. for its current position within the consumer durables sector. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections. A copy of this report featuring Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) is available at: www.TradersInsight.net/r/cnbc/7f00_ACHN.

Traders Insight has released research on Vertex Pharmaceuticals Incorporated for its changing role within the consumer durables sector. Vertex Pharmaceuticals Incorporated (Vertex) is in the business of discovering, developing, manufacturing and commercializing small molecule drugs for the treatment of serious diseases. To access the full research report on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) we welcome investors to visit: www.TradersInsight.net/r/cnbc/0c25_VRTX.

About Traders Insight
Find direction and insight with TradersInsight.net. Our model of enabling open collaboration between members is breaking new ground into the investment community. By tapping into the resources of the community, we are crowd-sourcing our reach. As a result - we have been able to identify some of the greatest moving companies on the market today. The evidence is in the results, join today and experience what you've been missing.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here